These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 17914052)

  • 1. Retro-orbital hemorrhage after thrombolysis for acute myocardial infarction.
    Cunneen TS; Morlet N
    N Engl J Med; 2007 Oct; 357(14):1448-9. PubMed ID: 17914052
    [No Abstract]   [Full Text] [Related]  

  • 2. Postoperative orbital hemorrhage following thrombolysis for acute myocardial infarction.
    Yuen VH; Dolman PJ
    Can J Ophthalmol; 1999 Feb; 34(1):33-5. PubMed ID: 10088061
    [No Abstract]   [Full Text] [Related]  

  • 3. Orbital haemorrhage complication following postoperative thrombolysis.
    Leong JK; Ghabrial R; McCluskey PJ; Mulligan S
    Br J Ophthalmol; 2003 May; 87(5):655-6. PubMed ID: 12714423
    [No Abstract]   [Full Text] [Related]  

  • 4. Intraocular haemorrhage after thrombolysis.
    Kaba RA; Cox D; Lewis A; Bloom P; Dubrey S
    Lancet; 2005 Jan 22-28; 365(9456):330. PubMed ID: 15664229
    [No Abstract]   [Full Text] [Related]  

  • 5. A case of intraocular haemorrhage secondary to thrombolytic therapy.
    Berry C; Weir C; Hammer H
    Acta Ophthalmol Scand; 2002 Oct; 80(5):561-2. PubMed ID: 12390175
    [No Abstract]   [Full Text] [Related]  

  • 6. [Ischemic ictus during thrombolytic treatment in acute myocardial infarct].
    Seijo-Martínez M; Pais A; Castro del Río M; Silva-Martínez M
    Rev Neurol; 2000 Oct 16-31; 31(8):798-9. PubMed ID: 11082894
    [No Abstract]   [Full Text] [Related]  

  • 7. [Thrombolytic agents, urokinase, tissue-type plasminogen activator and pro-urokinase--their routes of administration and dosage: comparison between intracoronary thrombolysis and intravenous coronary thrombolysis].
    Motomiya T
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():441-5. PubMed ID: 12735012
    [No Abstract]   [Full Text] [Related]  

  • 8. Hemorrhagic ocular complications associated with the use of systemic thrombolytic agents.
    Chorich LJ; Derick RJ; Chambers RB; Cahill KV; Quartetti EJ; Fry JA; Bush CA
    Ophthalmology; 1998 Mar; 105(3):428-31. PubMed ID: 9499772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early diagnosis of colonic carcinoma: a haemorrhagic complication after the use of tissue plasminogen activator.
    Baker JW; Mitchell SJ; Dixon AR
    Postgrad Med J; 2002 Jul; 78(921):429. PubMed ID: 12151663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Upper airway obstruction by angioedema following thrombolytic therapy with recombinant tissue plasminogen activator].
    García-Jiménez A; Iriarte Sotés P; Fernández González CJ; Garrote Freire A; González Tutor J
    An Med Interna; 2003 Mar; 20(3):163-4. PubMed ID: 12756909
    [No Abstract]   [Full Text] [Related]  

  • 11. Haematoma of the hand as a complication of thrombolysis for myocardial infarction.
    Ahmed K; Yavari A; Walker DM; Buchanan JA
    J Hand Surg Eur Vol; 2007 Dec; 32(6):720-1. PubMed ID: 17993444
    [No Abstract]   [Full Text] [Related]  

  • 12. Thrombolytic-related complication in a case of misdiagnosed myocardial infarction.
    Irivbogbe O; Mirrer B; Loarte P; Gale M; Cohen R
    Acute Card Care; 2014 Jun; 16(2):83-7. PubMed ID: 24749992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spinal epidural hematoma complicating thrombolytic therapy with tissue plasminogen activator--a case report.
    Clark MA; Paradis NA
    J Emerg Med; 2002 Oct; 23(3):247-51. PubMed ID: 12426015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is coronary thrombolysis associated with side effects that significantly compromise clinical benefits?
    Gurewich V; Muller J
    Am J Cardiol; 1996 Apr; 77(9):756-8. PubMed ID: 8651129
    [No Abstract]   [Full Text] [Related]  

  • 15. Spontaneous subperiosteal orbital hemorrhage following thrombolytic therapy for myocardial infarction.
    Diatchuk V; Rehany U; Rumelt S
    Ophthalmic Plast Reconstr Surg; 2007; 23(6):482-4. PubMed ID: 18030123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Future developments in thrombolytic therapy].
    Bode C; Runge MS
    Z Kardiol; 1993; 82 Suppl 2():187-90. PubMed ID: 8328201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spinal epidural hematoma associated with tissue plasminogen activator treatment of acute myocardial infarction.
    Baron EM; Burke JA; Akhtar N; Young WF
    Catheter Cardiovasc Interv; 1999 Dec; 48(4):390-6. PubMed ID: 10559822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case of the month: A case of airway obstruction following tenecteplase administration.
    Kirkham L; Homewood J; Brook P
    Emerg Med J; 2006 Oct; 23(10):815-6. PubMed ID: 16988319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous hemarthrosis following fibrinolytic therapy for acute myocardial infarction: a case report and literature review.
    Ramadan MM; Khan IS; Mahdi O
    Am J Case Rep; 2014 Nov; 15():514-7. PubMed ID: 25417208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experience with the thrombolytic therapy of myocardial infarct].
    Gospodarenko AL; Ardashev VN; Tiurin VP; Chernetsov VA; Iakovlev VB; Vrublevskiĭ OIu; Makarenko AS; Sokolianskiĭ NV; Chernov SA; Kucherov VV; Davrent'eva TA
    Voen Med Zh; 1997 Nov; 318(11):40-5. PubMed ID: 9461835
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.